SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8BE879CF3795137743818226CA7B943539491761F25E63CF9F513F1A76477AABF3425383308F143EC0EADB27609F220A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8BE879CF3795137743818226CA7B943539491761F25E63CF9F513F1A76477AABF3425383308F143EC0EADB27609F220A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8BE879CF3795137743818226CA7B943539491761F25E63CF9F513F1A76477AABF3425383308F143EC0EADB27609F220A
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that the Rho/ROCK signaling pathway may prove to be a promising target in anti-tumor therapy."
xsd:string
http://purl.uniprot.org/uniprot/#_34E32A2D723FA2268113FAB0012B075CB2765D825918E0237B1C1FB659A03713474AF57DB93D3488A4AB33F0D2C01CBD
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8BE879CF3795137743818226CA7B943539491761F25E63CF9F513F1A76477AABF3425383308F143EC0EADB27609F220A
http://purl.uniprot.org/uniprot/Q13464
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8BE879CF3795137743818226CA7B943539491761F25E63CF9F513F1A76477AABF3425383308F143EC0EADB27609F220A
http://purl.uniprot.org/uniprot/#_Q13464-mappedCitation-20364104
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8BE879CF3795137743818226CA7B943539491761F25E63CF9F513F1A76477AABF3425383308F143EC0EADB27609F220A